Cramer Rosenthal McGlynn’s BODY CENTRAL CORP COM STK BODY Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio BODY Stock Details BODY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-65,000	Closed	-$58K	–	291
2014 Q2	$58K	Hold	65,000	–	–	﹤0.01%	254
2014 Q1	$70K	Buy	65,000 +40,000	+160%	+$121K	﹤0.01%	258
2013 Q4	$99K	Sell	25,000 -39,258	-61%	-$170K	﹤0.01%	248
2013 Q3	$392K	Hold	64,258	–	–	﹤0.01%	230
2013 Q2	$856K	Buy	+64,258	New	+$710K	0.01%	216

Other funds holding BODY

DIS

Diversified Investment Strategies Baton Rouge, Louisiana $157M AUM 24.09% 1-Year Est. Return

Cramer Rosenthal McGlynn's BODY Position: Q3 2014 in Review

Cramer Rosenthal McGlynn sold out of BODY CENTRAL CORP COM STK (BODY) in Q3 2014, closing a stake of 65,000 shares — an estimated $58K sold.

Cramer Rosenthal McGlynn first reported a position in BODY in Q2 2013 and held it in 5 quarters. The position peaked at $856K in Q2 2013. 1 fund tracked by Wall St. Rank holds BODY as of Q3 2014.

Cramer Rosenthal McGlynn reported no remaining BODY CENTRAL CORP COM STK position as of Q3 2014 after selling out during the quarter.
Cramer Rosenthal McGlynn sold 65,000 BODY CENTRAL CORP COM STK shares in Q3 2014, an estimated $58K.
Cramer Rosenthal McGlynn first reported a position in BODY CENTRAL CORP COM STK in Q2 2013 and held it in 5 quarters.
Cramer Rosenthal McGlynn's BODY CENTRAL CORP COM STK position peaked at $856K in Q2 2013.
1 fund tracked by Wall St. Rank held BODY CENTRAL CORP COM STK as of Q3 2014.

Based on Cramer Rosenthal McGlynn's 13F filing for Q3 2014, filed 13 Nov 2014.